Status:

COMPLETED

Pain Managment in Preterm Neonates

Lead Sponsor:

Ain Shams University

Conditions:

Preterm Neonates Pain Managment

PreTerm Neonate

Eligibility:

All Genders

1-28 years

Phase:

PHASE2

PHASE3

Brief Summary

To compare the effect of Intranasal versus Intravenous Fentanyl on oxidative stress by measuring MDA level just before and after 30 minutes from painful procedure and comparing the results.

Detailed Description

1. Intra nasal fentanyl group: will receive intranasal fentanyl using nasal dose of INF is 1.5µg/kg/dose, and typically, one dose is given • After 5minutes, a second dose could be administrated ba...

Eligibility Criteria

Inclusion

  • • Preterm neonates during endotracheal intubation
  • \-

Exclusion

  • o Contraindication of fentanyl use as hypersensitivity.
  • Contraindication of nasal administration of drugs as bilateral occluded nasal passage as choanal atresia and Epistaxis.
  • Surgical patients.

Key Trial Info

Start Date :

February 1 2024

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

October 1 2024

Estimated Enrollment :

52 Patients enrolled

Trial Details

Trial ID

NCT07148882

Start Date

February 1 2024

End Date

October 1 2024

Last Update

August 29 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Ainshams Univercity

Cairo, Cairo Governorate, Egypt, 02

Pain Managment in Preterm Neonates | DecenTrialz